Sen. Casey asks Weis for price-freeze on more than 2,400 products
WASHINGTON Sen. Bob Casey, D-Pa., on Monday drafted a letter to David Hepfinger, president and CEO of Weis Markets, praising the grocer for implementing a 90-day price freeze on more than 2,400 products.
“This decision shows an admirable commitment to helping your customers in communities across Pennsylvania and beyond who are finding it harder every day to make ends meet and put nutritious meals on their families tables,” Casey wrote. “Without being asked, Weis Markets has chosen to respond to this need with vision and compassion. Your actions to hold down food prices will give families greater access to the food staples they need and help them make ends meet.”
Hy-Vee named official grocery partner of the K.C. Chiefs
WEST DES MOINES, Iowa A supermarket and retail pharmacy chain has become the official grocery partner of the Kansas City Chiefs.
Hy-Vee announced last week that it joined the Chiefs’ organization as its official grocery partner. The chain will be branded as an exclusive sponsor of the Chiefs at their home, Arrowhead Stadium in Kansas City, Mo., and at Missouri and Kansas stores.
“Hy-Vee is thrilled to begin what we hope will be a long and successful relationship with the Kansas City Chiefs,” Hy-Vee SVP market Jon Wendel said in a statement, noting that the chain has been a sponsor of baseball team the Kansas City Royals since 2001. “Our company has been warmly welcomed in this region for many years, and we look forward to all the opportunities this relationship gives us to promote Chiefs excitement throughout our communities.”
Active ingredient in eye drug may work as hair loss treatment
NEW YORK A drug made by Irvine, Calif.-based Allergan for treating glaucoma and missing eyelashes may also work as a treatment for hair loss, according to published reports.
The Orange County Business Journal reported recently that bimatoprost – the active ingredient in the glaucoma drug Lumigan and the eyelash-growing drug Latisse – might be able to grow hair on the scalp, though more research is needed.
The company will attempt to create a formulation and begin clinical trials, the newspaper reported a company executive as saying in a conference call with analysts.